AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Syrrou, M Borghgraef, M Fryns, JP
Citation: M. Syrrou et al., Unusual chromosomal mosaicism in Wolf-Hirschhorn syndrome: del(4)(p16)/der(4)(qter-q31.3 :: pter-qter), AM J MED G, 104(3), 2001, pp. 199-203

Authors: Syrrou, M Fryns, JP
Citation: M. Syrrou et Jp. Fryns, Interstitial deletion of chromosome 11 (q22.3-q23.2) in a boy with mild developmental delay, J MED GENET, 38(9), 2001, pp. 621-624

Authors: Frints, SGM Fryns, JP Lagae, L Syrrou, M Marynen, P Devriendt, K
Citation: Sgm. Frints et al., Xp22.3;Yq11.2 chromosome translocation and its clinical manifestations, ANN GENET, 44(2), 2001, pp. 71-76

Authors: Van Buggenhout, GJCM van Ravenswaaij-Arts, C Mieloo, H Syrrou, M Hamel, B Brunner, H Fryns, JP
Citation: Gjcm. Van Buggenhout et al., Dysmorphology and mental retardation: molecular cytogenetic studies in dysmorphic mentally retarded patients, ANN GENET, 44(2), 2001, pp. 89-92

Authors: Rosser,"Efgrafov, O Syrrou, M Meitinger, TA Rubinsztein, DC Stefanescu, G Tolun, A
Citation: O. Rosser,"efgrafov et al., Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language (vol 67, pg 1526, 2000), AM J HU GEN, 68(4), 2001, pp. 1075-1075

Authors: Tsezou, A Kitsiou, S Galla, A Petersen, MB Karadima, G Syrrou, M Sahlen, S Blennow, E
Citation: A. Tsezou et al., Molecular cytogenetic characterization and origin of two de novo duplication 9p cases, AM J MED G, 91(2), 2000, pp. 102-106

Authors: Malamou-Mitsi, VD Syrrou, M Georgiou, I Pagoulatos, G Agnantis, NJ
Citation: Vd. Malamou-mitsi et al., Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression, J EXP CL C, 18(3), 1999, pp. 357-361

Authors: Patsalis, PC Sismani, C Hettinger, JA Boumba, I Georgiou, I Stylianidou, G Anastasiadou, V Koukoulli, R Pagoulatos, G Syrrou, M
Citation: Pc. Patsalis et al., Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: Incidence, genetic variation, and stability, AM J MED G, 84(3), 1999, pp. 184-190

Authors: Syrrou, M Georgiou, I Patsalis, PC Bouba, I Adonakis, G Papoulatos, GN
Citation: M. Syrrou et al., Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction, AM J MED G, 84(3), 1999, pp. 306-308

Authors: Allingham-Hawkins, SJ Babul-Hirji, R Chitayat, D Holden, JJA Yang, KT Lee, C Hudson, R Gorwill, H Nolin, SL Glicksman, A Jenkins, EC Brown, WT Howard-Peebles, PN Becchi, C Cummings, E Fallon, L Seitz, S Black, SH Vianna-Morgante, AM Costa, SS Otto, PA Mingroni-Netto, RC Murray, A Webb, J MacSwinney, F Dennis, N Jacobs, PA Syrrou, M Georgiou, I Patsalis, PC Uzielli, MLG Guarducci, S Lapi, E Cecconi, A Ricci, U
Citation: Sj. Allingham-hawkins et al., Fragile X premutation is a significant risk factor for premature ovarian failure: The international collaborative POF in fragile X study - Preliminary data, AM J MED G, 83(4), 1999, pp. 322-325

Authors: Georgiou, I Syrrou, M Bouba, I Dalkalitsis, N Paschopoulos, M Navrozoglou, I Lolis, D
Citation: I. Georgiou et al., Association of estrogen receptor gene polymorphisms with endometriosis, FERT STERIL, 72(1), 1999, pp. 164-166
Risultati: 1-11 |